RecruitingNCT03225586

Prospective Urban Rural Epidemiology Study

Sponsor

Population Health Research Institute

Enrollment

200,000 participants

Start Date

Jan 1, 2002

Study Type

OBSERVATIONAL

Conditions

Cancer Cardiovascular Diseases Lung Diseases Risk Factor, Cardiovascular Health Behavior Environmental Exposure Injuries Renal Disease Communicable Disease

Summary

To examine the impact of health determinants at the individual (e.g. health related behaviors) and societal level (e.g. environmental factors, health related policy, quality of health systems) on health outcomes (e.g. death, non-communicable disease development) across a range of socioeconomic and health resource settings. Additional components of this study will examine genetic factors for non-communicable diseases. This will be examined both through a cross sectional component, and prospectively (cohort component).

Eligibility

Min Age: 35 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This large international study is following people in both cities and rural areas over time to understand how where you live affects your risk of heart disease, stroke, cancer, diabetes, and other serious health conditions. **You may be eligible if...** - You are an adult between 35 and 70 years old - You are willing to give your consent to participate **You may NOT be eligible if...** - There are no medical exclusions listed — almost anyone in this age range may qualify Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(34)

Estudios Clinicos Latinoamerica ECLA

Rosario, Santa Fe Province, Argentina

Independent University, Bangladesh

Dhaka, Bangladesh

Dante Pazzanese Institute of Cardiology

São Paulo, Brazil

Simon Fraser University

Vancouver, British Columbia, Canada

Population Health Research Institute

Hamilton, Ontario, Canada

University of Ottawa

Ottawa, Ontario, Canada

Université Laval Institut universitaire de cardiologie et de pneumologie de Québec

Québec, Quebec, Canada

Universidad de La Frontera

Temuco, Chile

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital

Beijing, China

Fundacion Oftalmologica de Santander - FOSCAL

Floridablanca, Santander Department, Colombia

St John's Research Institute

Bangalore, Karnataka, India

Health Action by People

Thiruvananthapuram, Kerala, India

Eternal Heart Care Centre and Research Institute

Jaipur, Rajasthan, India

Madras Diabetes Research Foundation

Chennai, Tamil Nadu, India

Post Graduate Institute of Medical Education and Research (PGIMER)

Chandigarh, India

Isfahan University of Medical Sciences

Isfahan, Iran

Research Institute of Cardiology & Internal Diseases

Almaty, Kazakhstan

Kyrgyz Society of Cardiology, National Center of Cardiology and Internal Disease

Bishkek, Kyrgyzstan

Universiti Teknologi MARA, UCSI Universiti

Kuala Lumpur, Malaysia

University Kebangsaan Malaysia

Kuala Lumpur, Malaysia

Aga Khan University

Karachi, Pakistan

Birzeit University, Birzeit

Ramallah, Palestinian Territories

Universidad Peruana Cayetano Heredia

Lima, Peru

University of Philippines, Section of Adult Medicine & Medical Research Unit

Manila, Philippines

Wroclaw Medical University & Department of Internal Medicine

Wroclaw, Poland

Research Institute for Complex Issues of Cardiovascular Diseases

Kemerovo, Russia

King Saud University

Riyadh, Saudi Arabia

School of Public Health, University of the Western Cape

Bellville, South Africa

North-West University

Potchefstroom, South Africa

Sahlgrenska University Hospital/Östra Hospital

Gothenburg, Sweden

Pamoja Tunaweza Women Center

Moshi, Tanzania

Istanbul Medeniyet University

Istanbul, Turkey (Türkiye)

Dubai Medical University

Dubai, United Arab Emirates

University of Zimbabwe College of Health Sciences

Harare, Zimbabwe

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03225586

Related Trials

Patient-Centered Assessment of Symptoms and Outcomes

NCT039526241 location

Diabetes and Heart Disease Risk in Blacks

NCT000018531 location

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT055881411 location

Tumor Related Epilepsy

NCT026393251 location

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

NCT0643163330 locations